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Abstract M1 RNA, the catalytic component of Escherichia
coli RNase P, is derived from the 3P-end processing of precursor
M1 RNA, a major transcript of the rnpB gene. In this study, we
investigated the mechanism of 3P-end processing of M1 RNA
using the recombinant N-terminal half RNase E. The cleavage
site preference of RNase E di¡ered from that of the 40% am-
monium sulfate precipitate (ASP-40), a partially puri¢ed cell
extract containing processing activity. However, the addition
of a trace amount of ASP-40 changed the cleavage site prefer-
ence of RNase E to that of ASP-40 suggesting the involvement
of a soluble factor in cleavage site preference.
. 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
RNase E, an essential endonuclease of 1061 amino acids,
was initially characterized as the enzyme that processes 9S
rRNA to yield 5S rRNA in Escherichia coli [1]. Recently,
RNase E was shown to be the main component of the
mRNA degradation machinery (degradosome) [2^7]. The
N-terminal half (NTH) of RNase E contains the catalytic
site for its single-strand-speci¢c endonuclease activity, while
the C-terminal half of the enzyme functions as a sca¡old for
degradosome formation [8^12]. It has been reported that the
C-terminal half of RNase E is instrumental in degrading
mRNA, but dispensable for processing rRNA [13,14]. Recent
studies also have shown that RNase E is required for the
initiation of tRNA maturation and that this function is essen-
tial role of RNase E for the cell viability [15,16].
Another endonuclease, RNase P, is a tRNA processing en-
zyme responsible for cleaving the 5P-leader sequence to gen-
erate the mature 5P-end of tRNA [17,18]. E. coli RNase P
contains a 377 nucleotide RNA called M1, which functions
as the catalytic subunit of the enzyme and is formed through a
processing event. M1 RNA is transcribed from the rnpB gene
as a precursor molecule called pM1 RNA [18^20], which is
processed at the 3P-end to generate the mature M1 RNA [21^
25]. Although the processing activity has not been fully char-
acterized, several studies have shown that it is related to
RNase E activity. Gurevitz et al. [22] have shown that pM1
RNA accumulates at non-permissive temperatures in a tem-
perature-sensitive RNase E mutant strain. However, they
found that partially puri¢ed RNase E does not catalyze this
processing event in vitro. Therefore, they postulated that
RNase E is indirectly involved in the processing. However,
Lundberg and Altman [23] reported that RNase E activity
correlates with the 3P-end processing activity of M1 RNA,
suggesting the direct involvement of RNase E. This notion
is supported by the presence of a pentanucleotide sequence
immediately adjacent to the processing site, GAUUU, that
matches the consensus sequence of the RNase E cleavage
site (the rne-dependent site) (Fig. 1; [26]). Alteration of the
GAUUU sequence a¡ects the processing e⁄ciency in vivo and
in vitro [24,27] lending further support for the direct involve-
ment of RNase E. Furthermore, 3P-end processing of M1
RNA is a complex process involving two multi-step pathways
[28]. So it is still unclear how RNase E activity is involved in
the processing of M1 RNA.
In this study, we examined the 3P-end processing of M1
RNA in vitro using the N-terminal catalytic half of RNase
E. The results suggest that RNase E directly participates in
one of the processing pathways (pathway II), and is also in-
volved in the second step of the other processing pathway
(pathway I). Interestingly, the cleavage site preference of
RNase E in pathway II was di¡erent from that of the 40%
ammonium sulfate precipitate (ASP-40), a partially puri¢ed
cell extract containing processing activity. However, this
cleavage site preference can be changed to that of ASP-40
by the addition of a trace amount of ASP-40 suggesting the
involvement of a soluble factor in cleavage site preference.
2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli JM109 [29] was used for the construction of plasmids and
the preparation of cell extract. The expression vector pET21b from
Novagene was used for expression of the recombinant RNase E.
Plasmid pSPd23 contains the rnpB transcription unit with an internal
deletion of the sequence between +57 and +330, and carries the SP6
promoter linked to the 5P-end of the M1 RNA-coding sequence and a
DraI site at position +415 [24]. pSPM1p is also a derivative of pAL-
TER-1, which was equivalent to pSPd23 but having the intact rnpB
sequence to generate pM1 RNA [28].
2.2. Expression and puri¢cation of the recombinant RNase E and
RNase G
For construction of pRNEN, an expression plasmid for the His-
tagged NTH of RNase E, the 1584-bp fragment encoding the N-ter-
minal 528 residues of the rne gene was generated by PCR ampli¢ca-
tion of the corresponding region of E. coli chromosomal DNA with
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the oligonucleotide primer pairs 5P-CCGGATCCGATGAAAA-
GAATGTTAATCAA-3P and 5P-GTCTCGAGCGCAGGTTGTTCC-
3P. The PCR product was cut with BamHI and XhoI, and cloned into
pET21b. The NTH of RNase E was overexpressed in E. coli
BL21(DE3) cells containing pRNEN. Cells were grown exponentially
in Luria^Bertani medium containing ampicillin (50 Wg/ml) at 30‡C
with shaking. At an A600 of 0.5^0.6, isopropyl-D-thiogalactoside was
added to a ¢nal concentration of 1 mM, and the cultures were incu-
bated for an additional 2 h. The cells were collected by centrifugation
at 4‡C. The pelleted cells were resuspended in column bu¡er (10 mM
Tris^HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA) and sonicated on ice.
After sonication, the supernatant fraction was subjected to Ni-NTA
a⁄nity chromatography as described in the pET System Manual (No-
vagen). The protein preparation was concentrated after dialysis
against 50 mM Tris^HCl, pH 7.5, 20% glycerol, 1 mM EDTA, 500
mM NaCl and 0.5% Triton X-100. The concentration of the protein
was determined by the BCA method [30].
To construct pRNG, an expression plasmid for the His-tagged
RNase G, we ampli¢ed the rng coding region with the primer pairs
5P-GCCCGGGCATATGACGGCTGAATTGTTAGTAAACG-3P
and 5P-GCGCTCGAGCATCATTACGACGTCAAACTGCTCC-3P.
The PCR product was cut with NdeI and XhoI, and cloned into
pET21a. The recombinant RNase G was overexpressed and puri¢ed
by the same methods as described above for the NTH-RNase E.
2.3. In vitro transcription of substrates
The plasmids pSPd23 and pSPM1p were cleaved with DraI for the
generation of p23 RNA and pM1 RNA, respectively, and used as
templates for in vitro transcription by SP6 RNA polymerase [27]. A
DNA template for transcripts having a 3P-end of +386 was con-
structed as described [27]. In vitro transcripts were labeled at the 3P-
end with [32P]pCp and T4 RNA ligase, or internally with [K-32P]CTP,
as described [31]. RNA products were puri¢ed before use by gel elu-
tion, as described [31].
2.4. In vitro processing assay
The ASP-40 of the S30 fraction was prepared as a partially puri¢ed
cell extract from E. coli JM109, as described [24]. RNA substrates of
0.2 pmol were incubated with the ASP-40 fraction or the recombinant
protein at 37‡C in 50 mM Tris^HCl, pH 7.5, 60 mM NH4Cl, 10 mM
MgCl2, 0.5 mM DTT, and 0.1 mM phenylmethylsulfonyl £uoride, as
described [24]. Yeast tRNA at a concentration of 0.7 mg/ml was
added into the reaction mixture when both the ASP-40 fraction and
the recombinant RNase E were included in the same reaction. Yeast
total RNA (0.7 mg/ml) was added in the reaction mixture when re-
quired. The reaction products were extracted with phenol:chloro-
form:isoamyl alcohol (25:24:1) and analyzed by electrophoresis on
a polyacrylamide sequencing gel containing 8 M urea. The cleavage
preference was calculated as a ratio of the amount of each processed
RNA to that of the total processed RNA as determined by an image
analyzer BAS-1500 (Fuji).
2.5. Gel permeability chromatography (GPC)
The S30 fraction which was prepared from E. coli JM109 as de-
scribed [24], and the a⁄nity-puri¢ed NTH-RNase E were applied to a
FPLC system with HiLoad 16/60 Superdex chromatography (Pharma-
cia). The £ow rate was kept at 1 ml/min with bu¡er A containing 50
mM Tris^HCl, pH 7.5, 60 mM NH4Cl, 10 mM MgCl2, and 0.5 mM
Fig. 1. A: The secondary structure of M1 RNA surrounding the
processing site. The arrowhead indicates the 3P-end of the mature
M1 RNA. The rne-dependent site is underlined. B: Schematic repre-
sentation of pM1 RNA and p23 RNA. The rectangle indicates the
structural sequence of M1 RNA. The internal deletion points in p23
RNA are indicated by wavy lines and numbers, at which an EcoRI
linker sequence of 8 nucleotides was inserted [24]. The transcription
terminator is indicated by the stem^loop structure.
Fig. 2. Preparation of the recombinant RNase E and RNase G.
A: Structure of RNase E. The minimal NTH for retaining endonu-
clease activity [10] is indicated by the hatched rectangle. The solid
bar indicates the NTH used for the preparation of the recombinant
RNase E. B: E. coli BL21(DE3) cells containing pRNEN were
grown and induced with 1 mM IPTG. The expressed recombinant
RNase E as a His-tagged fusion protein was puri¢ed by Ni-NTA
a⁄nity chromatography. The protein samples were analyzed on a
10% SDS^polyacrylamide gel. Lane 1, total proteins of the unin-
duced E. coli cells; lane 2, total proteins of the IPTG-induced E. coli
cells ; lane 3, the puri¢ed recombinant RNase E (1 Wg); lane 4, total
proteins of E. coli cells overexpressing His-tag fused RNase G; lane
5, the puri¢ed recombinant RNase G (5 Wg). SM, size markers. C:
Puri¢cation of NTH-RNase E by GPC. The Ni-NTA a⁄nity-puri-
¢ed NTH-RNase E was subjected to GPC. Ultraviolet absorption
of eluants was monitored. Elution points of standard proteins were
indicated on the elution pro¢le.
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DTT for the whole time of the run. Two milliliter fractions were
collected.
3. Results
3.1. In vitro processing of pM1 RNA with recombinant
RNase E
We prepared the recombinant NTH-RNase E as a fusion
protein tagged at the C-terminus with six histidine residues.
The protein was puri¢ed by Ni-NTA a⁄nity chromatography
as a single band on an SDS^polyacrylamide gel (Fig. 2).
The NTH-RNase E was used for the in vitro cleavage re-
action of pM1 RNA. Indeed, the recombinant NTH-RNase E
cleaved pM1 RNA at the expected processing site (Fig. 3A).
However, it was very di⁄cult to determine the cleavage site at
the nucleotide level because pM1 RNA is a relatively long
RNA molecule. Therefore, we also investigated the processing
of p23 RNA, a truncated pM1 RNA by NTH-RNase E (Fig.
3B). This truncated RNA has been successfully used as a
model substrate for the study of 3P-end processing of M1
RNA both in vivo and in vitro [24,27,28], and provided a
more accurate determination of the cleavage speci¢city at sin-
gle nucleotide resolution. p23 RNA was cleaved by NTH-
RNase E to yield exclusively the processing product (termed
+379 RNA) having the 3P-ends of +379 (90% preference over
+378 RNA). This cleavage site preference di¡ered from that
of ASP-40 as a partially puri¢ed cell extract containing pro-
cessing activity. ASP-40 generated the processing products
(termed +378/+379 RNA) having the 3P-ends of +378 and
+379 with the preference of the 3P-end of +378 (60% prefer-
ence). The error was generally 10% or less. These results were
con¢rmed by repeating the experiment several times using
di¡erent extract preparations. To determine whether both
cleavage reactions occurred by endonucleolytic mechanisms,
the substrates were 3P-end labeled with 32P and assessed in the
processing assay (Fig. 4). The 3P-cleavage fragments matched
their cleavage site preference in the processing reaction with
the internally labeled substrates. Actually, the corresponding
3P-cleavage products from the internally labeled substrate
were also observed with a relatively short running time on a
10% polyacrylamide gel (data not shown), as shown elsewhere
[28]. pM1 RNA was also labeled at the 3P-end and used as a
substrate for the cleavage reaction. The di¡erence in cleavage
site preference between NTH-RNase E and ASP-40 was the
same as that for p23 RNA. The matching of the cleavage site
preference between the processing reactions with the internally
and 3P-end-labeled substrates indicates that the cleavage site
preference is the result of endonucleolytic cleavage by both
NTH-RNase E and ASP-40, and not the result of 3P-end
trimming by an exoribonuclease activity following the endo-
nucleolytic cleavage reaction.
If another endonuclease is responsible for the +378 cleav-
Fig. 3. In vitro processing reactions. Substrate RNA molecules, pM1 RNA (A), p23 RNA (B, C), and +386 intermediate RNA (D) were inter-
nally labeled with [K-32P]CTP. The labeled RNA substrates were incubated at 37‡C with ASP-40 (2 Wg of protein), with 10 ng of NTH-RNase
E, or the indicated amounts of RNase G. In vitro reaction products were electrophoresed on 5% polyacrylamide sequencing gels. GPC stands
for the NTH-RNase E protein that was further puri¢ed by GPC.
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age, RNase G would be a candidate since it is homologous to
the N-terminal catalytic domain of RNase E [32]. Therefore,
we tested whether RNase G could cleave p23 RNA. However,
the recombinant RNase G as a His-tag fused protein did not
generate any cleavage products (Fig. 3C), while it was active
on the RNA I substrate (data not shown).
ASP-40 also generates additional products (termed +385/
+386 RNA) with the 3P-ends of +385 and +386, which are
further processed to +378/+379 RNA [28]. +385/+386 RNA
intermediates are usually not observed because ASP-40 rap-
idly processes them [24]. However, these RNA intermediates
accumulate in the presence of excess yeast total RNA which
inhibits their further processing [24,28]. Currently, it is not
known whether RNase E was responsible for the generation
of +385/+386 intermediates. As shown in Fig. 3, the recombi-
nant NTH-RNase E did not generate +385/+386 intermedi-
ates not even in the presence of yeast total RNA (data not
shown). These results suggest that RNase E is involved in
3P-end processing of M1 RNA through pathway II by endo-
nucleolytically generating +379 RNA, and not through path-
way I by generating +385/+386 intermediates.
The processing of the +386 intermediate to +378/+379
RNA, which is the second step of pathway I, has been
thought to be rne-independent because this step occurs with
ASP-40 isolated from rne-3071 mutant cells. Since the inter-
mediate RNA was also cleaved by NTH-RNase E (Fig. 3D),
multiple enzymes seem to be involved in the processing of
+385/+386 RNA to +378/+379 RNA. However, RNase G
does not seem to be responsible for this process because
RNase G did not cleave the intermediate RNA (Fig. 3D, lanes
4 and 5).
3.2. The presence of a cellular factor alters cleavage speci¢city
by NTH-RNase E
We examined whether the di¡erence of the cleavage prefer-
ence between NTH-RNase E and ASP-40 arises from the lack
of the C-terminal half of RNase E or from the presence of a
cellular factor in ASP-40. For this purpose, we carried out the
processing reaction by NTH-RNase E in the presence of ASP-
40 (Fig. 5). The addition of ASP-40 inhibited the processing
activity of NTH-RNase E, probably due to the presence of
large amounts of RNA in ASP-40. To reduce the inhibition
e¡ect of ASP-40, we added excess yeast tRNA to the reaction.
However, because the additional yeast tRNA also inhibited
NTH-RNase E activity, we instead used a large amount of
NTH-RNase E in the processing reactions. We ¢rst varied the
amount of NTH-RNase E in the in vitro processing assay
with 2 Wg of ASP-40. This amount of ASP-40 alone generated
a very small amount of products, but changed the cleavage
site preference of NTH-RNase E to that of ASP-40 (Fig. 5A).
The generation of products with the changed cleavage site
preference increased with the amount of NTH-RNase E that
was added to the processing reaction, indicating that the
cleaving activity with the change of the cleavage site prefer-
ence originated from NTH-RNase E and not from ASP-40.
This means that the change in the cleavage site preference was
not due to the lack of the C-terminal half of RNase E. Alter-
natively, we varied the amount ASP-40 in the in vitro pro-
cessing assay with a ¢xed amount of NTH-RNase E (Fig.
5A). Interestingly, a trace amount of ASP-40 was su⁄cient
to change the cleavage site preference of NTH-RNase E.
These results suggest there might be a factor or factors in
ASP-40 that can alter cleavage site speci¢city. We also exam-
ined whether the addition of ASP-40 would modify the NTH-
Fig. 5. Alteration of the cleavage preference of NTH-RNase E in
the presence of ASP-40. A: p23 RNA was internally labeled with
[K-32P]CTP. The labeled RNA was incubated with increasing
amounts of NTH-RNase E (5^20 Wg) in the presence of the ¢xed
amount of ASP-40 (2 Wg of protein) at 37‡C for 5 min. Alterna-
tively, the labeled RNA was incubated with increasing amounts of
ASP-40 (0.5^2 Wg of protein) at the ¢xed amount of NTH-RNase E
(20 Wg). B: The labeled p23 RNA was incubated with 20 Wg of
RNase E in the presence of ASP-40 (0.5 Wg of protein). The pres-
ence and absence of excess yeast total RNA (yT RNA) in the reac-
tion mixture are indicated as plus (+) and minus (3). C: The la-
beled p23 RNA was added after the preincubation of ASP-40 (0.5
Wg of protein) with 5 Wg of NTH-RNase E for 5 min.
Fig. 4. Identi¢cation of downstream cleavage products. RNA sub-
strates labeled at the 3P-end with [32P]pCp were incubated with 10
ng of NTH-RNase E or ASP-40 (2 Wg of protein) and analyzed on
a 10% polyacrylamide sequencing gel. OH indicates alkaline hydro-
lysis ladders. G stands for G-speci¢c (RNase T1) cleavage products.
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RNase E activity to produce the +385/+386 RNA intermedi-
ates. In this experiment, we included excess yeast total RNA
in the in vitro processing assay to exclude the possibility that
+385/+386 RNA could be further processed by the added
ASP-40 [28]. The addition of ASP-40 did not induce NTH-
RNase E to generate the +385/+386 RNA intermediates (Fig.
5B).
One may still argue that the cleavage at the +378 position is
produced by an activity in the ASP-40. This argument comes
from the possible limitation of cleavage of the p23 RNA by
the enzyme within the ASP-40: this enzyme activity might be
competitively inhibited by some RNA molecules that are in-
cluded in the ASP-40. The addition of NTH-RNase E would
result in the preferential decay of any competitive inhibitor
RNA, thereby enhancing the +378 cleavage. To test this pos-
sibility, we preincubated ASP-40 with NTH-RNase E before
adding the substrate so that any competitive inhibitor RNA
would be degraded. However, we did not ¢nd any enhancing
e¡ect on the +378 cleavage by this preincubation (Fig. 5C).
Therefore, no enzyme other than NTH-RNase E seems to be
responsible for the +378 cleavage.
With a purpose to identify the factor a¡ecting the cleavage
Fig. 6. Alteration of the cleavage preference of NTH-RNase E by fractions of the S30 cell extract separated through GPC. A: Fractions were
analyzed on a 10% SDS^polyacrylamide gel. The internally labeled (B) or the 3P-end labeled (C) p23 RNA substrate was incubated with 100
ng of RNase E in the presence of 10 Wl of each fraction at 37‡C for 5 min. The reaction products were analyzed on 5% or 10% polyacrylamide
sequencing gels. G stands for G-speci¢c (RNase T1) cleavage products of the substrate. The relative cleavage preference represents a relative in-
crease of the +378 cleavage product by the addition of each fraction.
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speci¢city of NTH-RNase E, we tried to separate proteins
included in the ASP-40 according to their size by GPC. Be-
cause the separating condition was non-denaturing, most of
the proteins were obtained in the form of complexes (Fig. 6A).
When the processing activity of each fraction was tested, the
processing activity was isolated with fractions 29, 30, and 31,
which were eluted at about 60 min, showing the majority of
the processing activity (data not shown). We examined the
e¡ect of each fraction on the cleavage preference of NTH-
RNase E by adding a trace amount of the fraction in the
processing reaction. Fractions 33^35 changed the cleavage
preference of NTH-RNase E from position +379 to +378
(Fig. 6B). Fractions 28^33 caused the generation of the
+377 cleavage product in addition to the +378 cleavage prod-
uct. To assess whether the +377 and +378 cleavage products
were generated by endonucleolytic cleavage reaction or by a
trimming reaction mediated by exoribonucleases, the 3P-end-
labeled substrate was used in the same processing assay. The
3P-end cleavage fragment by endonucleolytic cleavage at the
+378 site slightly increased with the addition of fractions
33^35. This increase was not as much as that shown with
the internal labeled substrate. These data suggest that frac-
tions 33^35 carry an exoribonuclease that is responsible
for one-nucleotide trimming at the 3P-end, in addition to the
factors that a¡ect the cleavage preference of NTH-RNase E.
In contrast, the 3P-endonucleolytic fragment corresponding
to the +377 cleavage that occurred in the presence of frac-
tions 28^33 was not observed. Therefore, fractions 28^33 must
contain an exoribonuclease that catalyzes the trimming reac-
tion to generate the 3P-end of +377. This result con¢rms that
the +377 RNA is formed after the initial endonucleolytic
cleavage by trimming one- or two-nucleotides at the 3P-end
[33].
4. Discussion
In this study, we showed the direct involvement of RNase E
in the 3P-end processing of M1 RNA using NTH-RNase E as
the catalytic domain of RNase E. NTH-RNase E cleaves ex-
clusively the phosphodiester bond after the +379 nucleotide.
One may argue that this processing activity would be due to
E. coli proteins copuri¢ed with NTH-RNase E during the
puri¢cation by Ni-NTA a⁄nity chromatography. To exclude
this possibility, we further puri¢ed NTH-RNase E by GPC.
The GPC-puri¢ed NTH-RNase E, which was eluted as a sin-
gle peak of about 60 kDa (Fig. 2C), did not show any con-
taminating protein band in a silver-staining SDS^polyacryl-
amide gel (data not shown). The processing activity of the
GPC-puri¢ed NTH-RNase E was the same as that of NTH-
RNase E puri¢ed from the Ni-NTA a⁄nity column (Fig.
3C,D). The cleavage site by NTH-RNase E di¡ers from the
cleavage site preference of ASP-40, a partially puri¢ed cell
extract that cleaves the phosphodiester bonds after nucleotide
positions +378 and +379 with a cleavage site preference at
position +378. This cleavage site preference was changed to
that of ASP-40 by the addition of a trace amount of ASP-40
in the NTH-RNase E reaction. This result suggests that the
change in the cleavage site preference originated from the
presence of a cellular factor in ASP-40, rather than the lack
of the C-terminal half of RNase E in NTH-RNase E.
Although the identity of this putative cellular factor is un-
known, it would have to be a factor that could interact with
the RNA substrate or the N-terminal region of RNase E to
alter the cleavage speci¢city of RNase E.
Why is the cleavage speci¢city of RNase E changed by a
cellular factor? One possible explanation would be that cleav-
age speci¢city is controlled by various cellular factors in vivo.
In this respect, it is noteworthy that RNase E is not only an
RNA processing enzyme but also a core enzyme of the general
RNA degradation machinery (degradosome) [2^7]. A single
nucleotide change at the 3P-end may cause a signi¢cant change
in the stability of the RNA or in its processing. It is not
known at this time whether the two RNA molecules having
di¡erent 3P-ends of +378 and +379 are processed through
di¡erent pathways. It may be possible since the two nucleotide
di¡erence in length at the 3P-end of pM1 RNA itself deter-
mines by which processing pathway it will follow [28]. If this
was the case, the change of the cleavage site speci¢city would
be a prerequisite for the function of RNase E as a processing
enzyme.
When the S30 cell extract was fractionated using a size-
exclusion column, we observed the change in the cleavage
site by NTH-RNase E with the addition of some fractions.
However, the cleavage products were produced not only by
the change of the endonucleolytic cleavage site, but also by
the action of exoribonucleases. This exoribonuclease activity
was not observed in the ASP-40 or the S30 fraction [27,28].
Exoribonuclease activities may normally be tightly regulated
in the cell, since the 3P-end of RNA can be an important
signal for the destination of RNA [28,34]. Therefore, the ap-
pearance of the exoribonuclease activity in size exclusion frac-
tions of S30 might result from disruption of the normal reg-
ulation in the cell by fractionation of the cell extract.
We previously showed that 3P-end processing of M1 RNA
occurs through two processing pathways [27,28]. In pathway
I, pM1 RNA is cleaved to generate the +385/+386 RNA
intermediates (the ¢rst step), which are subsequently pro-
cessed to generate +378/+379 RNA (the second step). Experi-
ments with cell extracts derived from an E. coli strain carrying
the rne-3071 mutation responsible for thermosensitivity of
RNase E function showed that the second step is rne-indepen-
dent [28]. However, in this paper, we showed that the puri¢ed
NTH-RNase E could cleave the intermediate RNA at the
expected site. These data suggest that the second step of path-
way I can occur by multiple enzymes including RNase E. The
rne-dependency of the ¢rst step of pathway I was unclear
because this step itself was temperature-dependent. In path-
way II, pM1 RNA is directly processed to generate +378/+379
RNA and this step is rne-dependent [28]. NTH-RNase E gen-
erated +379 RNA by an endonucleolytic cleavage, but it did
not generate the +385/+386 RNA intermediates (Figs. 3 and
5). Therefore, RNase E does not seem to be involved in the
generation of the +385/+386 intermediates.
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